Brain+ Investor Relations Material

Brain+ A/S, identified by the stock symbol BRAINP, is a healthcare company based in Copenhagen, Denmark, specializing in health information services. The company focuses on the development of digital therapeutics for Alzheimer's and dementia. Its product pipeline includes a variety of solutions aimed at cognitive stimulation therapy (CST) and computerized cognitive training for patients with mild cognitive impairment or early stages of Alzheimer's. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Copenhagen Stock Exchange.